Bookman Michael 4
4 · Immuneering Corp · Filed Feb 9, 2024
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
Transactions
- Award
Stock Option
2024-02-08+93,000→ 93,000 totalExercise: $6.09Exp: 2034-02-08→ Class A Common Stock (93,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.